Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · September 08, 2022

Type 2 Diabetes Subgroups and Response to Glucose Level–Lowering Therapy

Diabetes, Obesity & Metabolism


Additional Info

Diabetes, Obesity & Metabolism
Type 2 diabetes subgroups and response to glucose-lowering therapy: Results from the EDICT and Qatar studies
Diabetes Obes Metab 2022 Sep 01;24(9)1810-1818, T Abdul-Ghani, C Puckett, O Migahid, S Abdelgani, A Migahed, J Adams, C Triplitt, R DeFronzo, A Jayyousi, M Abdul-Ghani

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading